
Godavari Drugs Faces Significant Volatility Amid Persistent Downward Trend in Stock Performance
2025-03-03 14:20:55Godavari Drugs, a microcap in the Pharmaceuticals & Drugs sector, has faced notable volatility, hitting a new 52-week low. The stock has declined 9.55% over four days and is trading below key moving averages, reflecting ongoing challenges and a significant drop of 20.26% over the past year.
Read More
Godavari Drugs Hits 52-Week Low Amid Broader Sector Challenges and Declines
2025-02-28 13:05:30Godavari Drugs, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low of Rs. 81 amid significant volatility. The stock has declined 8.99% over three days and is underperforming its sector, which has also faced challenges, reflecting broader market struggles.
Read More
Godavari Drugs Hits New Low Amid Sustained Downward Trend in Pharmaceuticals Sector
2025-02-19 09:37:13Godavari Drugs has reached a new 52-week low, marking its eighth consecutive day of losses and a significant decline over the past week. The stock has underperformed the broader market over the past year and is trading below multiple moving averages, indicating ongoing challenges within the company and the industry.
Read More
Godavari Drugs Faces Significant Volatility Amid Sustained Downward Trend in Pharmaceuticals Sector
2025-02-17 14:10:42Godavari Drugs, a microcap in the Pharmaceuticals & Drugs sector, has faced significant volatility, hitting a new 52-week low. The stock has declined consecutively over six days, with a notable drop over the past year, contrasting with the overall positive performance of the Sensex.
Read More
Godavari Drugs Reports December 2024 Results, Signals Shift in Financial Performance
2025-02-12 20:05:54Godavari Drugs has announced its financial results for the quarter ending December 2024, revealing a significant shift in its financial performance. The company's stock assessment has undergone a notable revision, indicating changes in its underlying financial metrics that may impact stakeholders' perspectives on its operational health.
Read MoreClosure of Trading Window
27-Mar-2025 | Source : BSEPlease find the Intimation of Closure of Trading Window
Announcement under Regulation 30 (LODR)-Newspaper Publication
13-Feb-2025 | Source : BSENews Paper clippings of Unaudited Financial Results for the Third Quarter ended December 31 2024
Board Meeting Outcome for Outcome Of The Board Meeting Of Godavari Drugs Limited (The Company) Held On Wednesday 12Th February 2025
12-Feb-2025 | Source : BSEConsidered and approved the un-audited financial results of the Company prepared as per Indian Accounting Standard (Ind-AS) along with Limited Review Report thereon for the quarter and nine months ended December 31 2024
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available